Farxiga
Payments companies reported to CMS as associated with Farxiga. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Farxiga, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Farxiga
These are the largest totals companies reported as associated with Farxiga. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ankit Mehta | Dallas, TX | Nephrology (Internal Medicine) | $256,749.91 |
| Christian Mende | La Jolla, CA | $201,423.15 | |
| Derek Larson | Creve Coeur, MO | Nephrology (Internal Medicine) | $173,851.03 |
| Carlos Bejar | Fort Lauderdale, FL | Nephrology (Internal Medicine) | $172,195.02 |
| Lance Sloan | Lufkin, TX | Endocrinology, Diabetes & Metabolism | $132,191.93 |
| Drew Heiple | Russellville, AR | Nephrology (Internal Medicine) | $96,780.83 |
| Gates Colbert | Dallas, TX | Nephrology (Internal Medicine) | $88,307.80 |
| Gregory Greenwood | Winston-Salem, NC | Nephrology (Internal Medicine) | $87,598.45 |
| Matthew Budoff | Torrance, CA | Cardiovascular Disease | $84,026.54 |
| Anthony Blalock | Lafayette, LA | Nephrology (Internal Medicine) | $78,711.27 |
Prescribed Farxiga?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.